HFpEF Diagnosis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — HFpEF
Exertional dyspnoea with preserved LVEF (≥50%), elevated E/e' ratio (≥13), elevated LAVI, LVH, elevated NT-proBNP, and AF with typical risk factors (elderly, obese, hypertensive, female) is HFpEF. H2FPEF score supports the diagnosis. Treatment: diuretics (decongestion), SGLT2 inhibitors (DELIVER trial: empagliflozin reduced HF events in HFpEF), GLP-1 RA for obesity (STEP-HFpEF: semaglutide improved symptoms), and management of comorbidities. No mortality-reducing pharmacotherapy for HFpEF was proven until SGLT2i.
Reference: NHFA/CSANZ – 2023 – HFpEF; DELIVER Trial; ESC 2021